Developing a Model to Predict Inpatient Hypoglycemic Episodes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-31

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will create a new model to predict hypoglycemic events in diabetic inpatients on anti-hyperglycemic therapy using retrospective data with the goal of developing a model that will accurately predict hypoglycemic episodes in the patient population - piloting the risk score that was developed in the context of EndoTool being rolled out at the institution, to determine the feasibility and acceptability of viewing the risk score in the Electronic Health Record

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of a Primary Care Hypoglycemia Prevention Program

NCT06353217

Diabetes Mellitus Hypoglycemia

ACTIVE_NOT_RECRUITING NA

Preventing Hypoglycemia

NCT01923688

Diabetes

COMPLETED NA

Hypoglycemia Prediction Model

NCT03006510

Hypoglycemia

COMPLETED NA

Diagnosing and Treating Low Blood Sugar Levels

NCT00001276

Hypoglycemia Insulinoma

RECRUITING

Liver Glycogen and Hypoglycemia in Humans

NCT03241706

Hypoglycemia; Iatrogenic

ACTIVE_NOT_RECRUITING PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Design a model to predict hypoglycemic episodes in real time, rather than retrospectively identifying high risk patients who experienced a hypoglycemic event at some point during their hospitalization, as has been done prior. Potential predictors of hypoglycemia identified in prior work and additional predictors identified by the clinical team to develop a discrete-time multinomial logistic regression model to predict hypoglycemic events in real time. The risk score then will be piloted in the context of our institution's EndoTool Subcutaneous implementation determine the feasibility and acceptability of viewing the risk score in the Electronic Health Record

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypoglycemic Events Hyperglycemic Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool

Service where the experimental hypoglycemia risk score is applied on a service which has already implemented EndoTool

Group Type EXPERIMENTAL

EndoTool

Intervention Type DIAGNOSTIC_TEST

EndoTool is a vendor based glucose management software

Service where EndoTool is applied without the experimental hypoglycemia risk score

Service where EndoTool is applied without our experimental hypoglycemia risk score

Group Type ACTIVE_COMPARATOR

glucose management team

Intervention Type OTHER

comparison group will be services that have not yet implemented EndoTool

Standard of care glucose management

Service which has not yet implemented EndoTool - providers adjusting insulin and consulting the Glucose Management Team at their discretion

Group Type ACTIVE_COMPARATOR

standard of care glucose management

Intervention Type OTHER

providers adjusting insulin and consulting the Glucose Management Team at their discretion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EndoTool

EndoTool is a vendor based glucose management software

Intervention Type DIAGNOSTIC_TEST

glucose management team

comparison group will be services that have not yet implemented EndoTool

Intervention Type OTHER

standard of care glucose management

providers adjusting insulin and consulting the Glucose Management Team at their discretion

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Providers taking care of adult patients (18 years and older) on the selected medical floors who are receiving anti-hyperglycemic medications on the chosen services (EndoTool and risk score implementation) and comparison groups (one group with EndoTool implementation and the other group without EndoTool implementation)